Vitamin D in the new millennium

Current Osteoporosis Reports

Volumn 10, Issue 1, 2012, Pages 4-15

  Wimalawansa, Sunil J ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Bone mineral density (BMD); Fractures; Osteomalacia; Osteoporosis; Rickets; Supplements; Syndrome; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D; 25 HYDROXYERGOCALCIFEROL; BONE DENSITY CONSERVATION AGENT;

ARTICLE; BARIATRIC SURGERY; BLOOD VESSEL CALCIFICATION; BONE DENSITY; BONE METABOLISM; CLINICAL FEATURE; DEHYDRATION; FALLING; FRACTURE REDUCTION; HEADACHE; HOMEOSTASIS; HUMAN; HYPERCALCEMIA; INCIDENCE; IRRITABILITY; KIDNEY CALCIFICATION; KIDNEY DISEASE; NAUSEA; NONHUMAN; PANCREATITIS; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; RISK REDUCTION; SIDE EFFECT; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; VOMITING; VULNERABLE POPULATION; BLOOD; HEALTH CARE POLICY; PATHOPHYSIOLOGY; REVIEW;

25-HYDROXYVITAMIN D 2; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; HUMANS; NUTRITION POLICY; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84862268940     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-011-0094-8     Document Type: Article

References (162)

1. Bosomworth NJ. Mitigating epidemic vitamin D deficiency: The agony of evidence. Can Fam Physician. 2011;57(1):16-20.
2. Ginde AA, Liu MC, Camargo Jr CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009;169(6):626-32.
3. Goldstein D. The epidemic of vitamin D deficiency. J Pediatr Nurs. 2009;24(4):345-6.
4. Bodnar LM, Catov JM, Simhan HN, et al. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007;92(9):3517-22. (Pubitemid 47435329)
5. Bodnar LM, Catov JM, Zmuda JM, et al. Maternal serum 25- hydroxyvitamin D concentrations are associated with smallfor- gestational age births in white women. J Nutr. 2010;140 (5):999-1006.
6. Lewis S, Lucas RM, Halliday J, et al. Vitamin D deficiency and pregnancy: from preconception to birth. Mol Nutr Food Res. 2010;54(8):1092-102.
7. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37(1):113-9. (Pubitemid 351228619)
8. Ginde AA, Mansbach JM, Camargo Jr CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169(4):384-90.
9. Chesney RW. Vitamin D and The Magic Mountain: the antiinfectious role of the vitamin. J Pediatr. 2010;156(5):698-703.
10. Levin AD, Wadhera V, Leach ST, et al. Vitamin D Deficiency in Children with Inflammatory Bowel Disease. Dig Dis Sci 2011.
11. Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96(2):252-61. (Pubitemid 43167123)
12. Giovannucci E, Liu Y, Willett WC. Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2467-72. (Pubitemid 46048306)
13. Hisatake J, O'Kelly J, Uskokovic MR, et al. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood. 2001;97(8):2427-33. (Pubitemid 32291490)
14. Morales-Tirado V, Wichlan DG, Leimig TE, et al. 1alpha,25- dihydroxyvitamin D3 (vitamin D3) catalyzes suppressive activity on human natural regulatory T cells, uniquely modulates cell cycle progression, and augments FOXP3. Clin Immunol. 2011;138 (2):212-21.
15. Ng KY, Ma MT, Leung KK, et al. Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas. Stem Cell Rev. 2011;7(1):53-63.
16. Kilpinen-Loisa P, Nenonen H, Pihko H, et al. High-dose vitamin D supplementation in children with cerebral palsy or neuromuscular disorder. Neuropediatrics. 2007;38(4):167-72.
17. Bolland MJ, Bacon CJ, Horne AM, et al. Vitamin D insufficiency and health outcomes over 5 y in older women. Am J Clin Nutr. 2010;91(1):82-9.
18. Tai K, Need AG, Horowitz M, et al. Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition. 2008;24(10):950-6.
19. Sneve M, Figenschau Y, Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol. 2008;159(6):675-84.
20. Binkley N. Is vitamin D the fountain of youth? Endocr Pract. 2009;15(6):590-6.
21. Norman AW, Bouillon R, Whiting SJ, et al. 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol. 2007;103(3-5):204-5. (Pubitemid 46420528)
22. Binkley N. Does low vitamin D status contribute to "age- related" morbidity? J Bone Miner Res. 2007;22 Suppl 2:V55-8. (Pubitemid 351304650)
23. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81(3):353-73. (Pubitemid 43334631)
24. Holick MF. Vitamin D: a D-Lightful health perspective. Nutr Rev. 2008;66(10 Suppl 2):S182-94.
25. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25- hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or 060 y. Am J Clin Nutr. 2004;80(3):752-8. (Pubitemid 41115542)
26. Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int. 2002;13(3):187-94. (Pubitemid 34408183)
27. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005;293(18):2257-64. (Pubitemid 40629192)
28. Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ. 2005;330(7498):1003.
29. Avenell A, Gillespie WJ, Gillespie LD, et al. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009, (2):CD000227.
30. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169(6):551-61.
31. Zhang HL, Wu J. Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis. Neurosci Bull. 2010;26(6):445-54.
32. Blaney GP, Albert PJ, Proal AD. Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Eur J Clin Invest. 2005;35:290-304.
33. Semba RD, Houston DK, Bandinelli S, et al. Relationship of 25- hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr. 2010;64(2):203-9.
34. Wang L, Manson JE, Song Y, et al. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010;152(5):315-23.
35. Drechsler C, Pilz S, Obermayer-Pietsch B, et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J. 2010;31(18):2253-61.
36. Pilz S, Tomaschitz A, Drechsler C, et al. Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets. 2011;12(1):88-96.
37. Wimalawansa SJ. Vitamin D: Everything You Need to Know. Homagama, Sri Lanka. Publisher: Karunaratne & Sons, 2011. This is a comprehensive book on vitamin D primarily directed for the primary care physicians.
38. Jenab M, Bueno-de-Mesquita HB, Ferrari P, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case- control study. BMJ. 2010;340:b5500.
39. Karlsson S, Olausson J, Lundh D, et al. Vitamin D and prostate cancer: the role of membrane initiated signaling pathways in prostate cancer progression. J Steroid Biochem Mol Biol. 2010;121(1-2):413-6.
40. Holick MF, Siris ES, Binkley N, et al. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005;90 (6):3215-24. (Pubitemid 41014278)
41. Seton M, Jackson V, Lasser KE, et al. Low 25-hydroxyvitamin D and osteopenia are prevalent in persons>or 055 yr with fracture at any site: a prospective, observational study of persons fracturing in the community. J Clin Densitom. 2005;8(4):454-60. (Pubitemid 41690407)
42. Kuchuk NO, Pluijm SM, van Schoor NM, et al. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab. 2009;94(4):1244-50.
43. Orwoll E, Nielson CM, Marshall LM, et al. Vitamin D deficiency in older men. J Clin Endocrinol Metab. 2009;94(4):1214-22.
44. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326(7387):469-72. (Pubitemid 36269626)
45. Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2008;93 (3):677-81. (Pubitemid 351398538)
46. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin d deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011, 96(7):1911-1930. These recommendations are primarily directed to individual patients; not intended for populations.
47. Romagnoli E, Mascia ML, Cipriani C, et al. Short and longterm variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008;93(8):3015-20.
48. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89(11):5387-91. (Pubitemid 39518413)
49. Binkley N, Gemar D, Engelke J, et al. Evaluation of Ergocalciferol or Cholecalciferol Dosing, 1,600 IU Daily or 50,000 IU Monthly in Older Adults. J Clin Endocrinol Metab 2011.
50. Wimalawansa SJ. Vitamin D: An essential component for skeletal health. Annals of NYAS. 2011;1240(1):90-104.
51. Chun RF, Adams JS, Hewison M. Back to the future: a new look at 'old' vitamin D. J Endocrinol. 2008;198(2):261-9.
52. Strushkevich N, Usanov SA, Plotnikov AN, et al. Structural analysis of CYP2R1 in complex with vitamin D3. J Mol Biol. 2008;380(1):95-106.
53. Fernandesdeabreu DA, Eyles D, Feron F. Vitamin D, a neuroimmunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009;34(1):265-77.
54. Bravo S, Paredes R, Izaurieta P, et al. The classic receptor for 1alpha,25-dihydroxy vitamin D3 is required for non-genomic actions of 1alpha,25-dihydroxy vitamin D3 in osteosarcoma cells. J Cell Biochem. 2006;99(4):995-1000. (Pubitemid 44673958)
55. De Boland AR, Boland RL. Non-genomic signal transduction pathway of vitamin D in muscle. Cell Signal. 1994;6(7):717-24. (Pubitemid 24363566)
56. Pitcher T, Buffenstein R. Intestinal calcium transport in mole-rats (Cryptomys damarensis and Heterocephalus glaber) is independent of both genomic and non-genomic vitamin D mediation. Exp Physiol. 1995;80(4):597-608.
57. Vazquez G, de Boland AR, Boland R. Stimulation of Ca2+ release-activated Ca2+ channels as a potential mechanism involved in non-genomic 1,25(OH)2-vitamin D3-induced Ca2+ entry in skeletal muscle cells. Biochem Biophys Res Commun. 1997;239(2):562-5. (Pubitemid 27489004)
58. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16(7):713-6. (Pubitemid 40933586)
59. Okazaki R. Vitamin D deficiency and vitamin D insufficiency. Nippon Naika Gakkai Zasshi. 2007;96(4):742-7.
60. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005;135 (2):317-22. (Pubitemid 40194499)
61. Li B, Byrjalsen I, Glendenning P, et al. Selective monitoring of vitamin D2 and D3 supplementation with a highly specific 25- hydroxyvitamin D3 immunoassay with negligible cross-reactivity to 25-hydroxyvitamin D2. Clin Chim Acta. 2009;404(2):144-8.
62. Binkley N, Krueger D. Evaluation and correction of low vitamin D status. Curr Osteoporos Rep. 2008;6(3):95-9.
63. Heaney RP, and Weaver CM. Calcium and vitamin D. Endocrinol Metab Clin North Am 2003, 32(1):181-194, vii-viii. (Pubitemid 36378640)
64. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80(6 Suppl):1678S-88.
65. Kleerekoper M, Schleicher RL, Eisman J, et al. Clinical applications for vitamin d assays: what is known and what is wished for. Clin Chem. 2011;57(9):1227-32.
66. Kushnir MM, Ray JA, Rockwood AL, et al. Rapid analysis of 25- hydroxyvitamin D(2) and D(3) by liquid chromatography-tandem mass spectrometry and association of vitamin D and parathyroid hormone concentrations in healthy adults. Am J Clin Pathol. 2010;134(1):148-56.
67. van den Ouweland JM, Beijers AM, Demacker PN, et al. Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(15-16):1163-8.
68. Adamec J, Jannasch A, Huang J, et al. Development and optimization of an LC-MS/MS-based method for simultaneous quantification of vitamin D2, vitamin D3, 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3. J Sep Sci. 2011;34(1):11-20.
69. El-Khoury JM, Reineks EZ, Wang S. Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues. Clin Biochem. 2011;44(1):66-76.
70. Jafri L, Khan AH, Siddiqui AA, et al. Comparison of high performance liquid chromatography, radio immunoassay and electrochemiluminescence immunoassay for quantification of serum 25 hydroxy vitamin D. Clin Biochem 2011, 44(10-11):864-868. These are detailed discussions and comparisons of various methodologies currenlty avaiable for the measurement of serum vitamin D.
71. Flicker L, Mead K, MacInnis RJ, et al. Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc. 2003;51(11):1533-8. (Pubitemid 37409586)
72. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76 (4):1536-8. (Pubitemid 16193572)
73. Sambrook PN, Cameron ID, Cumming RG, et al. Vitamin D deficiency is common in frail institutionalised older people in northern Sydney. Med J Aust. 2002;176(11):560. (Pubitemid 34649407)
74. Harris SS. Vitamin D and African Americans. J Nutr. 2006;136 (4):1126-9.
75. Zubillaga P, Garrido A, Mugica I, et al. Effect of vitamin D and calcium supplementation on bone turnover in institutionalized adults with Down's Syndrome. Eur J Clin Nutr. 2006;60 (5):605-9. (Pubitemid 43922880)
76. Deplas A, Debiais F, Alcalay M, et al. Bone density, parathyroid hormone, calcium and vitamin D nutritional status of institutionalized elderly subjects. J Nutr Health Aging. 2004;8(5):400-4. (Pubitemid 39273812)
77. Harinarayan CV, Ramalakshmi T, Prasad UV, et al. High prevalence of low dietary calcium, high phytate consumption, and vitamin D deficiency in healthy south Indians. Am J Clin Nutr. 2007;85(4):1062-7. (Pubitemid 46557922)
78. Klein GL, Wimalawansa SJ, Kulkarni G, et al. The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study. Osteoporos Int. 2005;16(6):631-5. (Pubitemid 40897460)
79. Roy DK, Berry JL, Pye SR, et al. Vitamin D status and bone mass in UK South Asian women. Bone. 2007;40(1):200-4. (Pubitemid 44839328)
80. van der Meer IM, Middelkoop BJ, Boeke AJ, et al. Prevalence of vitamin D deficiency among Turkish, Moroccan, Indian and sub- Sahara African populations in Europe and their countries of origin: an overview. Osteoporos Int 2010.
81. Korpershoek HW, Witteman EM, Meinardi JR, et al. Severe vitamin D deficiency and hypocalcaemia after bariatric surgery. Ned Tijdschr Geneeskd. 2010;154:A827.
82. Arvold DS, Odean MJ, Dornfeld MP, et al. Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. Endocr Pract. 2009;15(3):203-12.
83. Marti F, Naumann UK, Suter PM, et al. [Vitamin D deficiency (in adults). Main symptoms: bone pain]. Praxis (Bern 1994) 2006, 95 (50):1953-1959; quiz 1960.
84. Nogues X, Servitja S, Pena MJ, et al. Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer. Maturitas. 2010;66 (3):291-7.
85. Messinger-Rapport B, Dumas LG. Falls in the nursing home: a collaborative approach. Nurs Clin North Am. 2009;44(2):187-95.
86. Dharmarajan TS, Akula M, Kuppachi S, et al. Vitamin D deficiency in community older adults with falls of gait imbalance: an underrecognized problem in the inner city. J Nutr Elder. 2005;25(1):7-19. (Pubitemid 44200079)
87. Joop PW, van den Bergh, Bours SPG, et al. Optimal Use of Vitamin D When Treating Osteoporosis. Osteoporos Rep. 2011;9(1):36-42.
88. Broe KE, Chen TC, Weinberg J, et al. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc. 2007;55(2):234-9. (Pubitemid 46184399)
89. Greenspan SL, Resnick NM, Parker RA. Vitamin D supplementation in older women. J Gerontol A Biol Sci Med Sci. 2005;60 (6):754-9. (Pubitemid 40881183)
90. Kalyani RR, Stein B, Valiyil R, et al. Vitamin D treatment for the prevention of falls in older adults: systematic review and metaanalysis. J Am Geriatr Soc. 2010;58(7):1299-310.
91. Fleet JC, Schoch RD. Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors. Crit Rev Clin Lab Sci. 2010;47(4):181-95.
92. Heaney RP, Dowell MS, Hale CA, et al. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003;22(2):142-6. (Pubitemid 36417827)
93. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22(4):477-501. (Pubitemid 32762324)
94. Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, et al. Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res. 2009;24(5):935-42.
95. Cauley JA, Lacroix AZ,Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008;149(4):242-50.
96. Gerdhem P, Ringsberg KA, Obrant KJ, et al. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int. 2005;16(11):1425-31. (Pubitemid 41534648)
97. Parfitt A. Osteomalacia and related disorders. In: Metabolic bone disease and clinically related disorders, Edited by Avioli LV, and Krane SM. Philadelphia: WB Saunders Company; 1990: 329-396.
98. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of Vitamin D on falls: a meta-analysis. JAMA. 2004;291 (16):1999-2006. (Pubitemid 38544282)
99. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992;327(23):1637-42.
100. Adams JS, Kantorovich V, Wu C, et al. Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab. 1999;84(8):2729-30. (Pubitemid 30642001)
101. Heaney RP. Barriers to optimizing vitamin D3 intake for the elderly. J Nutr. 2006;136(4):1123-5.
102. Pattanaungkul S, Riggs BL, Yergey AL, et al. Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25 (OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action. J Clin Endocrinol Metab. 2000;85(11):4023-7. (Pubitemid 32055347)
103. Song Y, Kato S, Fleet JC. Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J Nutr. 2003;133(2):374-80. (Pubitemid 36172886)
104. Christakos S, Dhawan P, Porta A, et al. Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol 2011.
105. Christakos S, Dhawan P, Peng X, et al. New insights into the function and regulation of vitamin D target proteins. J Steroid Biochem Mol Biol. 2007;103(3-5):405-10. (Pubitemid 46401348)
106. Benn BS, Ajibade D, Porta A, et al. Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k. Endocrinology. 2008;149(6):3196-205. (Pubitemid 351724525)
107. Christakos S, Dhawan P, Benn B, et al. Vitamin D: molecular mechanism of action. Ann N Y Acad Sci. 2007;1116:340-8. (Pubitemid 350274347)
108. Richard C, Huo R, Samadfam R, et al. The calcium-sensing receptor and 25-hydroxyvitamin D-1alpha-hydroxylase interact to modulate skeletal growth and bone turnover. J Bone Miner Res. 2010;25(7):1627-36.
109. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001;142(12):5050-5. (Pubitemid 33131929)
110. Lewiecki EM MP, McClung MR, Cohen SB, Liu Y, Wang A, Fitzpatrick LA. Rank ligand inhibition with denosuman (AMG 162) increase bone mineral density (BMD) in postmenopausal women after two-years of treatment. In: American College of Rheumatology (ACR/ARHP) Annual Meeting2005.
111. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339: b3692.
112. Bergman GJ, Fan T, McFetridge JT, et al. Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: a meta-analysis. Curr Med Res Opin. 2010;26(5):1193-201.
113. Salovaara K, Tuppurainen M, Karkkainen M, et al. Effect of vitamin D(3) and calcium on fracture risk in 65- to 71-year-old women: a population-based 3-year randomized, controlled trial- the OSTPRE-FPS. J Bone Miner Res. 2010;25(7):1487-95.
114. Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009, (2):CD007146.
115. Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a metaanalysis. Lancet. 2007;370(9588):657-66. (Pubitemid 47285316)
116. Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, et al. Calcium intake and hip fracture risk in men and women: a metaanalysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr. 2007;86(6):1780-90. (Pubitemid 350232196)
117. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011, 96(1):53-58. This summary of the IOM report includes evidence-based recommendations for vitamin D.
118. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85(6):1586-91. (Pubitemid 46890428)
119. Elwood JM. Who gets skin cancer: individual risk factors. In: Prevention of Skin Cancer, Edited by Hill DJ, Elwood JM, and English DR. Dordrecht, the Netherlands: Kluwer Academic Publishers; 2004: 3-20.
120. Bogh MK, Schmedes AV, Philipsen PA, et al. Vitamin D production depends on ultraviolet-B dose but not on dose rate: a randomized controlled trial. Exp Dermatol. 2011;20 (1):14-8.
121. Bogh MK, Schmedes AV, Philipsen PA, et al. Interdependence between body surface area and ultraviolet B dose in vitamin D production: a randomized controlled trial. Br J Dermatol. 2011;164(1):163-9.
122. Robberecht E, Vandewalle S, Wehlou C, et al. Sunlight is an important determinant of vitamin D serum concentrations in cystic fibrosis. Eur J Clin Nutr. 2011;65(5):574-9.
123. Godar DE, Pope SJ, Grant WB, et al. Solar UV Doses of Young Americans and Vitamin D3 Production. Environ Health Perspect 2011.
124. Bonevski B, Girgis A, Magin P, et al. Prescribing sunshine: A cross-sectional survey of 500 Australian general practitioners' practices and attitudes about vitamin D. Int J Cancer 2011.
125. Clipp SL, Burke A, Hoffman-Bolton J, et al. Sun-seeking behavior to increase cutaneous vitamin D synthesis: when prevention messages conflict. Public Health Rep. 2011;126(4):533-9.
126. Ahmed SF, Franey C, McDevitt H, et al. Recent trends and clinical features of childhood vitamin D deficiency presenting to a children's hospital in Glasgow. Arch Dis Child. 2011;96(7):694-6.
127. Eastell R, Arnold A, Brandi ML, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94(2):340-50.
128. Khazai NB, Judd SE, Jeng L, et al. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. J Clin Endocrinol Metab. 2009;94(6):2037-43.
129. Chel VG, Ooms ME, Pavel S, et al. Prevention and treatment of vitamin D deficiency in Dutch psychogeriatric nursing home residents by weekly half-body UVB exposure after showering: a pilot study. Age Ageing. 2011;40(2):211-4.
130. Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol. 2011;11(9):584-96.
131. OldsWJ, McKinley AR, MooreMR, et al. In vitromodel of vitamin D3 (cholecalciferol) synthesis by UVradiation: dose-response relationships. J Photochem Photobiol B. 2008;93(2):88-93.
132. Kumar J, Muntner P, Kaskel FJ, et al. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics. 2009;124(3):e362-70.
133. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357 (3):266-81.
134. Looker AC, Pfeiffer CM, Lacher DA, et al. Serum 25- hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008;88(6):1519-27.
135. Adami S, Viapiana O, Gatti D, et al. Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. Bone. 2008;42(2):267-70.
136. Karakelides H, Geller JL, Schroeter AL, et al. Vitamin D-mediated hypercalcemia in slack skin disease: evidence for involvement of extrarenal 25-hydroxyvitamin D 1alpha-hydroxylase. J Bone Miner Res. 2006;21(9):1496-9. (Pubitemid 44300057)
137. Hewison M, Burke F, Evans KN, et al. Extra-renal 25- hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol. 2007;103(3-5):316-21. (Pubitemid 46420518)
138. Waele BD, Smitz J, Willems G. Recurrent pancreatitis secondary to hypercalcemia following vitamin D poisoning. Pancreas. 1989;4(3):378-80. (Pubitemid 19140842)
139. Hathcock JN, Shao A, Vieth R, et al. Risk assessment for vitamin D. Am J Clin Nutr. 2007;85(1):6-18. (Pubitemid 46067609)
140. Pietras SM, Obayan BK, Cai MH, et al. Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch Intern Med. 2009;169(19):1806-8.
141. Koutkia P, Chen TC, Holick MF. Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med. 2001;345(1):66-7. (Pubitemid 32634279)
142. Kaptein S, Risselada AJ, Boerma EC, et al. Life-threatening complications of vitamin D intoxication due to over-the-counter supplements. Clin Toxicol (Phila). 2010;48(5):460-2.
143. Institute of Medicine. Dietary reference intakes for calcium and vitamin D Washington, DC. Washington, DC.: Food and Nutrition Board 1997.
144. Food and Nutrition Board. Dietary reference intakes. Nutr Rev. 1997;55(9):319-26.
145. Vieth R, Bischoff-Ferrari H, Boucher BJ, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr. 2007;85(3):649-50. (Pubitemid 46393494)
146. Norman AW. A vitamin D nutritional cornucopia: new insights concerning the serum 25-hydroxyvitamin D status of the US population. Am J Clin Nutr. 2008;88(6):1455-6.
147. Moore CE, Murphy MM, Holick MF. Vitamin D intakes by children and adults in the United States differ among ethnic groups. J Nutr. 2005;135(10):2478-85. (Pubitemid 41429611)
148. Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets. 2011;12(1):4-18.
149. Chung M, Balk EM, Brendel M, et al. Vitamin D and calcium a systematic review of health outcomes. Evid Rep Technol Assess Full Rep. 2009;183:1-420.
150. Heaney RP. The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol. 2005;97(1-2):13-9. (Pubitemid 41546209)
151. U.S. Department of Health and Human Services. Healthy People U.S. Department of Health and Human Services. Available at http://www.healthypeople. gov/document/html/objectives/03-09.htm.
152. Reis JP, von Muhlen D, Miller 3rd ER, et al. Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population. Pediatrics. 2009;124:e371-9.
153. Chel VG, Ooms ME, Popp-Snijders C, et al. Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res. 1998;13 (8):1238-42. (Pubitemid 28373324)
154. Shah N, Bernardini J, Piraino B. Prevalence and correction of 25 (OH) vitamin D deficiency in peritoneal dialysis patients. Perit Dial Int. 2005;25(4):362-6. (Pubitemid 41136468)
155. Semba RD, Houston DK, Ferrucci L, et al. Low serum 25- hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women. Nutr Res. 2009;29(8):525-30.
156. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167(16):1730-7. (Pubitemid 47403059)
157. Melamed ML, Michos ED, Post W, et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629-37.
158. Giovannucci E, Liu Y, Hollis BW, et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168(11):1174-80. (Pubitemid 351831400)
159. Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820-5. (Pubitemid 41103882)
160. Choi HS, Kim KA, Lim CY, et al. Low serum vitamin D is associated with high risk of diabetes in Korean adults. J Nutr. 2011;141(8):1524-8.
161. Gupta AK, Brashear MM, Johnson WD. Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels. Diabetes Care. 2011;34(3):658-60.
162. Hamed EA, Abu Faddan NH, Adb Elhafeez HA, et al. Parathormone - 25(OH)-vitamin D axis and bone status in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2011;12(6):536-46.